New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors

Medicine & Life Sciences

• Bronchial Spasm 16%
• Carcinoid Tumor 29%
• Cytoreduction Surgical Procedures 16%
• Diarrhea 21%
• Drug Therapy 7%
• Everolimus 16%
• Gastro-enteropancreatic neuroendocrine tumor 100%
• Heart Valve Diseases 16%
• Histology 10%
• Hormones 9%
• lanreotide 20%
• Liver 13%
• Neoplasm Metastasis 15%
• Neoplasms 12%
• Octreotide 15%
• Palliative Care 12%
• Somatostatin 26%
• Sunitinib 16%
• Therapeutics 10%
• United States Food and Drug Administration 12%